MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 19.974
EU - Europa 13.552
AS - Asia 9.244
SA - Sud America 1.384
AF - Africa 283
OC - Oceania 96
Continente sconosciuto - Info sul continente non disponibili 18
Totale 44.551
Nazione #
US - Stati Uniti d'America 19.514
IT - Italia 6.767
SG - Singapore 2.922
GB - Regno Unito 2.410
CN - Cina 2.341
HK - Hong Kong 1.063
BR - Brasile 1.028
SE - Svezia 977
VN - Vietnam 968
DE - Germania 615
FR - Francia 550
FI - Finlandia 530
UA - Ucraina 377
TR - Turchia 376
RU - Federazione Russa 374
KR - Corea 275
IN - India 261
JP - Giappone 222
NL - Olanda 204
CA - Canada 200
ID - Indonesia 199
MX - Messico 192
IE - Irlanda 162
BG - Bulgaria 161
AR - Argentina 133
ZA - Sudafrica 89
AU - Australia 88
BD - Bangladesh 79
IQ - Iraq 76
PK - Pakistan 76
PL - Polonia 75
AE - Emirati Arabi Uniti 63
TN - Tunisia 58
EC - Ecuador 54
ES - Italia 49
MY - Malesia 49
CH - Svizzera 42
CL - Cile 42
LT - Lituania 42
CO - Colombia 39
BE - Belgio 35
PH - Filippine 34
IR - Iran 33
SA - Arabia Saudita 33
EG - Egitto 31
MA - Marocco 31
AT - Austria 28
PE - Perù 28
VE - Venezuela 28
UZ - Uzbekistan 23
RO - Romania 22
TH - Thailandia 22
JO - Giordania 21
DZ - Algeria 20
BZ - Belize 19
HU - Ungheria 19
KE - Kenya 19
NP - Nepal 19
EU - Europa 16
PT - Portogallo 15
TW - Taiwan 15
PY - Paraguay 14
DK - Danimarca 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
BO - Bolivia 10
IL - Israele 10
TT - Trinidad e Tobago 10
HR - Croazia 9
RS - Serbia 9
GR - Grecia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
AL - Albania 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
HN - Honduras 7
LV - Lettonia 7
KG - Kirghizistan 6
LB - Libano 6
LU - Lussemburgo 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
BY - Bielorussia 5
CY - Cipro 5
KZ - Kazakistan 5
QA - Qatar 5
SI - Slovenia 5
UY - Uruguay 5
KW - Kuwait 4
GT - Guatemala 3
GY - Guiana 3
ML - Mali 3
NI - Nicaragua 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UG - Uganda 3
Totale 44.505
Città #
Singapore 2.018
Santa Clara 1.991
Fairfield 1.722
Ashburn 1.614
Southend 1.515
Hong Kong 1.033
Woodbridge 941
Chandler 917
Houston 757
San Jose 703
Chicago 659
Wilmington 637
Hefei 619
Seattle 586
Jacksonville 565
Ann Arbor 531
Cambridge 530
Nyköping 513
Milan 494
Los Angeles 478
Rome 452
London 447
Beijing 416
Helsinki 407
Dearborn 387
The Dalles 348
Council Bluffs 304
Ho Chi Minh City 290
Salt Lake City 274
Modena 244
New York 244
Seoul 236
Hanoi 233
San Diego 182
Izmir 181
Sofia 152
Princeton 147
Jakarta 135
Dallas 134
Redwood City 132
Tampa 130
Dublin 127
Lauterbourg 122
Bologna 119
Elk Grove Village 119
Florence 114
Eugene 113
Shanghai 111
São Paulo 107
Naples 105
Bari 101
Moscow 100
Palermo 98
Buffalo 97
Frankfurt am Main 97
Tokyo 95
Catania 81
Bremen 77
Falls Church 71
Genoa 68
Orem 67
Mexico City 63
Des Moines 57
Sterling 57
Munich 56
Verona 56
Da Nang 54
Turin 53
Columbus 51
Lancaster 51
Boardman 50
Padova 50
Toronto 50
Chennai 47
Perth 47
Guangzhou 44
Phoenix 44
Miami 43
Johannesburg 41
Manchester 40
Cagliari 39
Atlanta 38
Warsaw 38
Mumbai 35
Amsterdam 34
Brooklyn 34
Denver 34
Dulles 34
Montreal 34
Paris 34
Ankara 33
Haiphong 32
Parma 32
San Francisco 32
Redondo Beach 31
Dong Ket 30
Salerno 30
Messina 29
Ottawa 29
Detroit 28
Totale 27.901
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.817
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.330
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.277
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 937
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 563
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 466
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 445
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 428
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 419
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 405
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 396
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 383
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 373
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 370
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 369
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 369
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 364
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 353
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 350
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 347
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 343
Cardiac Involvement in Systemic Vasculitis 342
Scleroderma digital ulcers complicated by infection with fecal pathogens. 340
Current treatment of hepatitis C-associated rheumatic diseases. 340
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 338
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 337
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 336
Aortic pulse wave velocity measurement in systemic sclerosis patients. 336
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 334
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 330
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 320
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 317
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 315
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 313
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 312
Platelet gel in the treatment of severe scleroderma skin ulcers. 303
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 301
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 298
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 296
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 295
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 292
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 291
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 287
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 285
Cardiovascular risk and prostanoids in systemic sclerosis 283
Acute exacerbation of interstitial lung disease associated with rheumatic disease 283
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 279
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 278
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 277
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 277
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 273
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 273
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 272
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 270
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 269
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 269
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 266
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 266
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 264
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 264
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 260
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 253
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 251
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 251
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 248
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 246
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 243
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 241
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 239
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 238
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 238
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 236
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 231
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 231
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 228
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 227
Osteomyelitis complicating scleroderma digital ulcers. 225
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 223
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 223
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
Procedural pain management in the treatment of scleroderma digital ulcers 218
Nailfold videocapillaroscopy in antisynthetase syndrome 218
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 217
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 215
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 215
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 213
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 212
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 210
A new chance to treat rheumatoid arthritis lung fibrosis? 209
Mixed cryoglobulinemia syndrome: where are we going to? 206
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 205
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 203
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 201
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 201
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 200
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 199
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 199
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 194
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 194
Totale 34.724
Categoria #
all - tutte 165.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.074 0 0 0 0 0 0 0 0 0 458 306 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/202613.308 800 516 1.011 2.020 3.042 1.045 1.737 647 1.320 1.170 0 0
Totale 45.004